Did you know the DNA in any cell of the human body – or any organism for that matter – contains the genetic information required to develop every possible type of cell within that organism? Yet cell types differ markedly from each other, both structurally and functionally. This is manifest through the production of different proteins encoded in the genetic information of the cell.
How is the information in DNA expressed as different proteins in diverse cells, such as those in a human liver, brain, heart or, maybe more pressing to ask, in a cancerous tumour? This kind of fundamental question is the focus of molecular biologists, particularly those with an evolutionary bent, who seek to understand how life evolved and how gene expression and cell development occur.
Jeffrey Fillingham, an associate professor in the Department of Chemistry and Biology at Ryerson University, and Ronald Pearlman, University Professor Emeritus in the Department of Biology at York University, are molecular biologists who ask these basic questions. Among their areas of interest, the two researchers study transcription and gene expression.
“Transcription is the process by which the information contained in DNA is turned into RNA, which carries the messages that direct the synthesis of proteins involved in making a particular cell,” said Pearlman. “The question is, ‘How, when, why and where are genes activated so they can be transcribed into cell-specific proteins?’”
Recently, a team based at Fillingham’s Ryerson research lab in the MaRS Discovery District explored this question, working with researchers in Pearlman’s group at York University and supported by others in Jack Greenblatt’s research group at the University of Toronto, as well as contributions from the SciNet HPC Consortium at the University of Toronto, along with Université Laval.
The team studied protein complexes involved in transcription using two experimental techniques: affinity purification and mass spectrometry. To do so, they looked at transcription in a single-cell eukaryotic (contains organelles such as the nucleus bounded by a membrane) model organism called Tetrahymena, which is an ideal system to study because it is easy to work with and manipulate molecularly, biochemically and genetically, and grows quickly. Its genome has more evolutionary similarity to humans than other non-mammalian model research organisms.
The objective of the study was to better understand the function of a protein complex called Mediator, which plays a central role in gene expression through transcription, with particular focus on a protein called Med31, a subunit of the Mediator complex.
Med31 is interesting to molecular biologists because it has been conserved through millennia of evolutionary change, which means that highly similar versions of the protein are found in organisms as divergent as Tetrahymena and human beings. (Tetrahymena Med31 has approximately 42 per cent sequence identity with human Med31.) Previous studies have demonstrated Med31 has ancient roots, is present in almost all organisms alive today, and plays a central role in cell development regulation in mammals.
These aspects of Med31 – and Mediator – lead to some interesting questions.
“The fact that Med31 is so conserved in evolution indicates that it plays some key fundamental role in transcription,” said Fillingham. “What is it doing? What is its role? Those are questions the answers to which nobody has really got at yet.”
The team’s investigation shed some light on the functioning of Mediator and Med31 in Tetrahymena by suggesting some ways that Mediator may function in developmental regulation for organisms. The findings were published in an article called “The Med31 Conserved Component of the Divergent Mediator Complex in Tetrahymena thermophila Participates in Developmental Regulation” in the highly regarded journal Current Biology, one of several in the prestigious Cell Press stable of journals.
Current Biology’s decision to publish the article is notable because it focuses on publication of research with a broad general interest, which means the journal editors and reviewers believe the findings of the research team are of interest and value to the wide biology community. What’s also interesting is that another paper using the same Tetrahymena model system published in the same journal issue reached similar conclusions to this study by asking different research questions, which amplifies the veracity of the team’s findings.
“In the field of transcription and gene expression, our findings are very interesting,” said Fillingham. “People will be interested to know how Tetrahymena Mediator is functioning in gene regulation and what this tells us more generally about transcription and regulation of gene expression.”
The three main contributors to the study were Pearlman’s long-time research associate at York University, Jyoti Garg; Fillingham’s current doctoral student at Ryerson, Alejandro Saettone; and Fillingham’s former master’s student, Syed Nabeel-Shah, who is now a doctoral candidate in the Department of Molecular Genetics at the University of Toronto in Greenblatt’s lab.
Other co-authors included Mathew Cadorin, another former master’s student in the Fillingham laboratory; Marcello Ponce, a bioinformatician associated with the SciNet consortium; Susanna Marquez, a former bioinformatics postdoctoral fellow in the Pearlman lab; and Shuye Pu, a bioinformatician associated with the Greenblatt laboratory. Rounding out the team was Jean-Phillipe Lambert, assistant professor in the Department of Molecular Medicine at Université Laval, who contributed his expertise in mass spectrometry to the project.